{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T16:20:46Z","timestamp":1788970846527,"version":"build-2803163510"},"reference-count":54,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2021.26126","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T15:48:14Z","timestamp":1632757694000},"page":"e2126126","source":"Crossref","is-referenced-by-count":28,"title":["Clinical and Demographic Factors Associated With Diabetic Retinopathy Among Young Patients With Diabetes"],"prefix":"10.1001","volume":"4","author":[{"given":"Michael L.","family":"Ferm","sequence":"first","affiliation":[{"name":"Baylor College of Medicine, Texas Children\u2019s Hospital, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"DeSalvo","sequence":"additional","affiliation":[{"name":"Pediatric Endocrinology and Metabolism, Baylor College of Medicine, Texas Children\u2019s Hospital, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Prichett","sequence":"additional","affiliation":[{"name":"Biostatistics, Epidemiology, and Data Management Core, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James K.","family":"Sickler","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine, Texas Children\u2019s Hospital, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risa M.","family":"Wolf","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roomasa","family":"Channa","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Wisconsin, Madison"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2021,9,27]]},"reference":[{"key":"zoi210768r1","author":"Svensson","year":"2016"},{"issue":"6","key":"zoi210768r2","doi-asserted-by":"publisher","first-page":"161","DOI":"10.15585\/mmwr.mm6906a3","article-title":"Trends in incidence of type 1 and type 2 diabetes among youths\u2014selected counties and Indian reservations, United States, 2002-2015.","volume":"69","author":"Divers","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"17","key":"zoi210768r3","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1001\/jama.2014.3201","article-title":"Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009.","volume":"311","author":"Dabelea","year":"2014","journal-title":"JAMA"},{"key":"zoi210768r4","author":"Lee","year":"2015"},{"issue":"3","key":"zoi210768r5","doi-asserted-by":"publisher","first-page":"556","DOI":"10.2337\/dc11-1909","article-title":"Global prevalence and major risk factors of diabetic retinopathy.","volume":"35","author":"Yau","year":"2012","journal-title":"Diabetes Care"},{"issue":"14","key":"zoi210768r6","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.","volume":"329","author":"Nathan","year":"1993","journal-title":"N Engl J Med"},{"issue":"3","key":"zoi210768r7","doi-asserted-by":"publisher","first-page":"631","DOI":"10.2337\/dc12-0863","article-title":"Assessing progress in retinopathy outcomes in type 1 diabetes: comparing findings from the Wisconsin Diabetes Registry Study and the Wisconsin Epidemiologic Study of Diabetic Retinopathy.","volume":"36","author":"LeCaire","year":"2013","journal-title":"Diabetes Care"},{"issue":"4","key":"zoi210768r8","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/dme.2013.30.issue-4","article-title":"Epidemiology of diabetic retinopathy and maculopathy in Africa: a systematic review.","volume":"30","author":"Burgess","year":"2013","journal-title":"Diabet Med"},{"key":"zoi210768r9","author":"Shibeshi","year":"2016"},{"issue":"10","key":"zoi210768r10","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1515\/jpem-2016-0231","article-title":"Prevalence and risk factors for diabetic retinopathy in a hospital-based population of Australian children and adolescents with type 1 diabetes.","volume":"29","author":"Keel","year":"2016","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"4","key":"zoi210768r11","doi-asserted-by":"publisher","first-page":"189","DOI":"10.4103\/meajo.MEAJO_208_19","article-title":"Pediatric diabetic retinopathy: experience of a tertiary hospital in Oman.","volume":"26","author":"Agroiya","year":"2020","journal-title":"Middle East Afr J Ophthalmol"},{"key":"zoi210768r12","doi-asserted-by":"crossref","DOI":"10.1111\/pedi.12688","article-title":"High rates of ocular complications in a cohort of Haitian children and adolescents with diabetes.","author":"Robinson","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"zoi210768r13","author":"Kang","year":"2018"},{"issue":"9","key":"zoi210768r14","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1210\/jc.2015-3604","article-title":"Association between HbA1c variability and risk of microvascular complications in adolescents with type 1 diabetes.","volume":"101","author":"Virk","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"zoi210768r15","author":"Wang","year":"2017"},{"issue":"6","key":"zoi210768r16","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1001\/jama.2010.1111","article-title":"Prevalence of diabetic retinopathy in the United States, 2005-2008.","volume":"304","author":"Zhang","year":"2010","journal-title":"JAMA"},{"key":"zoi210768r17","doi-asserted-by":"crossref","first-page":"l4894","DOI":"10.1136\/bmj.l4894","article-title":"HbA1c level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes: Swedish population based cohort study.","volume":"366","author":"Lind","year":"2019","journal-title":"BMJ"},{"key":"zoi210768r18","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.2337\/dc21-S007","article-title":"7. Diabetes technology: standards of medical care in diabetes\u20132021.","volume":"44","author":"American Diabetes Association","year":"2021","journal-title":"Diabetes Care"},{"issue":"2","key":"zoi210768r19","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1089\/dia.2018.0384","article-title":"State of type 1 diabetes management and outcomes from the T1D Exchange in 2016-2018.","volume":"21","author":"Foster","year":"2019","journal-title":"Diabetes Technol Ther"},{"key":"zoi210768r20","doi-asserted-by":"publisher","first-page":"S180","DOI":"10.2337\/dc21-S013","article-title":"13. Children and adolescents: standards of medical care in diabetes\u20132021.","volume":"44","author":"American Diabetes Association","year":"2021","journal-title":"Diabetes Care"},{"key":"zoi210768r22","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/pedi.2018.19.issue-S27","article-title":"ISPAD Clinical Practice Consensus Guidelines 2018: microvascular and macrovascular complications in children and adolescents.","volume":"19","author":"Donaghue","year":"2018","journal-title":"Pediatr Diabetes"},{"issue":"2","key":"zoi210768r23","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1001\/archophthalmol.2010.365","article-title":"Telemedicine and diabetic retinopathy: moving beyond retinal screening.","volume":"129","author":"Silva","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"zoi210768r24","author":"Gr\u00e4sbeck","year":"2016"},{"issue":"5","key":"zoi210768r25","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3928\/01913913-20140709-01","article-title":"Feasibility of retinal screening in a pediatric population with type 1 diabetes mellitus.","volume":"51","author":"Kolomeyer","year":"2014","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"zoi210768r26","author":"Wolf","year":"2021"},{"key":"zoi210768r27","author":"Lee","year":"2021"},{"issue":"10","key":"zoi210768r28","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1001\/jamaophthalmol.2020.3190","article-title":"Cost-effectiveness of autonomous point-of-care diabetic retinopathy screening for pediatric patients with diabetes.","volume":"138","author":"Wolf","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"zoi210768r29"},{"issue":"9596","key":"zoi210768r30","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"zoi210768r32","doi-asserted-by":"publisher","first-page":"S126","DOI":"10.2337\/dc18-S012","article-title":"12. Children and adolescents: Standards of Medical Care in Diabetes\u20132018.","volume":"41","author":"American Diabetes Association","year":"2018","journal-title":"Diabetes Care"},{"issue":"5","key":"zoi210768r33","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/pedi.v21.5","article-title":"Prevalence of diabetic retinopathy in children and adolescents at an urban tertiary eye care center.","volume":"21","author":"Porter","year":"2020","journal-title":"Pediatr Diabetes"},{"issue":"11","key":"zoi210768r34","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.2337\/dc11-0102","article-title":"Continued reduction in the prevalence of retinopathy in adolescents with type 1 diabetes: role of insulin therapy and glycemic control.","volume":"34","author":"Downie","year":"2011","journal-title":"Diabetes Care"},{"issue":"8","key":"zoi210768r35","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1001\/jama.2017.0686","article-title":"Association of type 1 diabetes vs type 2 diabetes diagnosed during childhood and adolescence with complications during teenage years and young adulthood.","volume":"317","author":"Dabelea","year":"2017","journal-title":"JAMA"},{"issue":"6","key":"zoi210768r36","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.2337\/dc12-2387","article-title":"Retinopathy in youth with type 2 diabetes participating in the TODAY clinical trial.","volume":"36","author":"TODAY Study Group","year":"2013","journal-title":"Diabetes Care"},{"key":"zoi210768r37","author":"Virk","year":"2015"},{"issue":"1","key":"zoi210768r38","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2337\/dc20-0904","article-title":"Progression of diabetic retinopathy and predictors of its development and progression during pregnancy in patients with type 1 diabetes: a report of 499 pregnancies.","volume":"44","author":"Bourry","year":"2021","journal-title":"Diabetes Care"},{"issue":"7","key":"zoi210768r39","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1089\/dia.2020.0031","article-title":"Time in range in children with type 1 diabetes using treatment strategies based on nonautomated insulin delivery systems in the real world.","volume":"22","author":"Cherubini","year":"2020","journal-title":"Diabetes Technol Ther"},{"issue":"8","key":"zoi210768r40","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range.","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"issue":"1","key":"zoi210768r41","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s13668-020-00347-9","article-title":"Artificial pancreas technology offers hope for childhood diabetes.","volume":"10","author":"Schoelwer","year":"2021","journal-title":"Curr Nutr Rep"},{"key":"zoi210768r42","author":"Barsegian","year":"2017"},{"issue":"7","key":"zoi210768r43","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1001\/jamaophthalmol.2021.1551","article-title":"Racial\/ethnic disparities and barriers to diabetic retinopathy screening in youths.","volume":"139","author":"Thomas","year":"2021","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"zoi210768r44","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/pedi.2014.15.issue-4","article-title":"Pediatric Diabetes Consortium Type 1 Diabetes New Onset (NeOn) study: factors associated with HbA1c levels one year after diagnosis.","volume":"15","author":"Redondo","year":"2014","journal-title":"Pediatr Diabetes"},{"issue":"2","key":"zoi210768r45","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1586\/17446651.2016.1145542","article-title":"When should screening for diabetic retinopathy begin for children with type 1 diabetes?","volume":"11","author":"Thomas","year":"2016","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"6","key":"zoi210768r46","first-page":"743","article-title":"Screening eye exams in youth with type 1 diabetes under 18 years of age: once may be enough?","volume":"20","author":"Gubitosi-Klug","year":"2019","journal-title":"Pediatr Diabetes"},{"issue":"4","key":"zoi210768r47","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1001\/archopht.1984.01040030398010","article-title":"The Wisconsin Epidemiologic Study of Diabetic Retinopathy. II. prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years.","volume":"102","author":"Klein","year":"1984","journal-title":"Arch Ophthalmol"},{"key":"zoi210768r48","author":"Geloneck","year":"2015"},{"issue":"7","key":"zoi210768r49","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/eye.2016.59","article-title":"Diagnosis of retinopathy in children younger than 12 years of age: implications for the diabetic eye screening guidelines in the UK.","volume":"30","author":"Hamid","year":"2016","journal-title":"Eye (Lond)"},{"key":"zoi210768r50","author":"Beauchamp","year":"2016"},{"key":"zoi210768r51","author":"Sauder","year":"2019"},{"issue":"7","key":"zoi210768r53","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1111\/pedi.v20.7","article-title":"Vulnerabilities in diabetic eye screening for children and young people in England.","volume":"20","author":"Ibanez-Bruron","year":"2019","journal-title":"Pediatr Diabetes"},{"issue":"4","key":"zoi210768r54","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1089\/tmj.2018.0019","article-title":"Diabetic retinopathy assessment variability among eye care providers in an urban teleophthalmology program.","volume":"25","author":"Liu","year":"2019","journal-title":"Telemed J E Health"},{"key":"zoi210768r21","author":"National Collaborating Centre for Women\u2019s and Children\u2019s Health (UK)","year":"2015"},{"key":"zoi210768r52","author":"Drews","year":"2019"},{"key":"zoi210768r31","unstructured":"Clinical growth charts. National Center for Health Statistics, Centers for Disease Control and Prevention. Accessed September 1, 2021. https:\/\/www.cdc.gov\/growthcharts\/clinical_charts.htm"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2784531\/ferm_2021_oi_210768_1632145994.82759.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T15:48:51Z","timestamp":1632757731000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2784531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,27]]},"references-count":54,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.26126","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,27]]}}}